Gilmore O'Neill - MassBio
4.9 (90) · $ 20.00 · In stock
Gilmore is President and Chief Executive Officer of Editas Medicine and a member of the Editas Board of Directors. He joined Editas Medicine in June 2022. Gilmore brings to Editas more than 20 years of experience in genetic medicine, neurobiology, and clinical development. Gilmore also has a track record of driving and leading several of […]
Gilmore O'Neill - CEO @ Editas Medicine - Crunchbase Person Profile
March, 2019
Editas Medicine Appoints Gilmore O'Neill as Chief Executive Officer
srpt-def14a_20190606.htm
March, 2019
SEC Filing Sarepta Therapeutics, Inc.
James M. O'Neill North Jersey Media Group
Management - About - MassBiologics - UMass Chan Medical School - Worcester
Staff – MassBioEd
SEC Filing Sarepta Therapeutics, Inc.
Malorie O'Neill - IMDb
5th CNS Drug Delivery 2023, December 5-7, Boston, MA
Biogen on X: #Biogen's Gilmore O'Neill is speaking today @MassBio #RareDiseaseDay event w/other local leaders #raredisease #patientadvocacy / X
SEC Filing - Unity Biotechnology
